Are You a Biomarker Pro?2025.04.24. Ready to flex your biomarker expertise? Accelsiors' 7-question quiz challenges you with real-world scenarios, rankings, and more. Get instant feedback and see if you’re a pro! Start now 1. Scenario: You’re designing an AD trial. Which biomarker confirms amyloid pathology? Blood NfL CSF Aβ42 DaT Scan microRNA None 2. Which assay detects PD 5 years before symptoms? FRET-Optima RT-QuIC SPR-Kinetic NeuroScope None 3. NeuroScope detects tau at 10 fg/mL—5x industry norms. True False None 4. Scenario: Your ALS trial needs a cost-effective progression tracker. Pick the best: Amyloid-PET Blood NfL APOE ε4 ThT Assay None 5. Order these assays by sensitivity (highest to lowest): RT-QuIC, NeuroScope, FRET-Optima RT-QuIC, FRET-Optima, NeuroScope NeuroScope, RT-QuIC, FRET-Optima FRET-Optima, NeuroScope, RT-QuIC None 6. Which assays aid drug screening? (Select all that apply) RT-QuIC FRET-Optima SPR-Kinetic NeuroScope Hint 7. Which biomarker secured a regulatory win in the past 18 months? FDA approval for amyloid-PET EMA validation for NfL FDA clearance for RT-QuIC EMA nod for CSF Aβ42 None Score 7/7? You’re a biomarker master! Unlock more: Sparks – Biomarkers in Clinical Trials for Neurodegenerative Diseases Aggregation Assays in Clinical Diagnostics and Drug Development We'd love to hear your insights and answer your questions.Schedule a meeting: [email protected] | Contact us Time's up
